Baxter International Inc

BAX

$36.91

Closing

▲1.01%

1D

▼-4.53%

YTD

BAX

BBG001S5P1K3

Market cap

$18.83B

52 week high

$44.01

52 week low

$31.02

Volume

693,389

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$18.83B

Analysts' Rating

HOLD

Price Target (Mean)

40.65

Total Analysts

15

P/E

Operating Margin

-5.04%

Beta

0.60

Revenue Growth

2.83%

52 week high

$44.01

52 week low

$31.02

Div. Yield

3.17%

EPS Growth

-985.71

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.